Nazila Habibizad

Companies

• Global Blood Therapeutics, Inc.Officer Mar 3, 2022 to Oct 6, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• GBGlobal Blood Therapeutics, Inc.0 shares²Oct 5, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Oct 5, 2022Returned to company 39,680 shares of Global Blood Therapeutics, Inc.²
• Oct 1, 2022Exercised options 182 shares of Global Blood Therapeutics, Inc.³
• Oct 1, 2022Exercised options 1,375 shares of Global Blood Therapeutics, Inc.³
• Sep 29, 2022Gift 3,500 shares of Global Blood Therapeutics, Inc.³
• Sep 27, 2022Exercised options 83 shares at $46.99 of Global Blood Therapeutics, Inc.⁴
• Sep 27, 2022Exercised options 1,027 shares at $48.44 of Global Blood Therapeutics, Inc.⁴
• Sep 27, 2022Exercised options 2,043 shares at $59.60 of Global Blood Therapeutics, Inc.⁴
• Sep 27, 2022Exercised options 3,005 shares at $29.75 of Global Blood Therapeutics, Inc.⁴
• Sep 27, 2022Exercised options 23,597 shares at $12.95 of Global Blood Therapeutics, Inc.⁴
• Sep 1, 2022Shares withheld for tax 1,342 shares at $68.15 of Global Blood Therapeutics, Inc.⁵
• Sep 1, 2022Exercised options 2,208 shares of Global Blood Therapeutics, Inc.⁵
• Sep 1, 2022Exercised options 1,670 shares of Global Blood Therapeutics, Inc.⁵
• Aug 31, 2022Granted 414 shares at $25.37 of Global Blood Therapeutics, Inc.⁵
• Aug 18, 2022Sold 4,678 shares at $67.19 of Global Blood Therapeutics, Inc.⁶
• Aug 1, 2022Shares withheld for tax 526 shares at $32.40 of Global Blood Therapeutics, Inc.⁷
• Aug 1, 2022Exercised options 1,518 shares of Global Blood Therapeutics, Inc.⁷
• Apr 1, 2022Shares withheld for tax 540 shares at $35.91 of Global Blood Therapeutics, Inc.⁸
• Apr 1, 2022Exercised options 1,558 shares of Global Blood Therapeutics, Inc.⁸
• Mar 1, 2022Shares withheld for tax 613 shares at $29.87 of Global Blood Therapeutics, Inc.⁹
• Mar 1, 2022Exercised options 1,671 shares of Global Blood Therapeutics, Inc.⁹